Tech News

Boston Dynamics Spot robot dog will soon come with an arm.

Spot, Boston Dynamics’ famous four-legged robot, is getting another upgrade. Founder Marc Raibert said that the company will start selling Spot with a robot arm, Emil Protalinski at Venture Beat reported. Raibert said that the arm will be available “in a few months.”

Spot just became available for commercial sale earlier this month. For $74,500 , Spot is ready for use by “developers eager to explore how flexible mobile robots can be adapted for tasks ranging from industrial inspection to entertainment.”

Currently, Spot is only available to US customers, and they can expect orders to be fulfilled in six to eight weeks after a $1,000 deposit.

The company suggests several uses for the dog-like robot: “Inspect dangerous, inaccessible, and remote environments,” “automate data collection on your site,” and “carry payloads on unstructured or unknown terrain.” The addition of an arm could potentially expand these uses.

Raibert also told Venture Beat that Spot will eventually be available for home use, using the example of a Spot model putting away laundry in a home. For now, Boston Dynamics’ terms and conditions clarify that Spot is not safe around children or in a home.

Even without the addition of an arm, Spot has already found many uses. Boston area hospitals started reaching out to Boston Dynamics in early March asking for robots that could help minimize staff exposure to COVID-19 . Spot robots were equipped with iPads and two-way robots to worth with COVID-19 patients at the hospital. Using this setup, doctors could talk to patients and evaluate symptoms from afar.

In New Zealand, Boston Dynamics’ Spot partnered with another company, Rocos, to herd sheep and collect agricultural data . Rocos said that its software will make Spot more useful on remote missions, and make the data collected by Spot more useful and accessible to remote teams.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close

Adblock Detected

Please consider supporting us by disabling your ad blocker